Introduction
============

Rheumatic heart disease (RHD) is a chronic acquired heart disorder resulting from acute rheumatic fever (ARF). Although rare in developed countries, RHD continues to be a major cause of cardiac morbidity and mortality among children and young adults in the developing countries.[@b1-jbm-6-151],[@b2-jbm-6-151] So far about 15 million cases of RHD are reported worldwide, with 282,000 new cases and 233,000 deaths occurring annually.[@b3-jbm-6-151] RHD is more common in females.[@b4-jbm-6-151] Although ARF causes pancarditis, it primarily affects the endocardium and repeated episodes of autoimmune reactions cause chronic inflammation in the valvular apparatus. Rheumatic mitral stenosis (RMS) is a common manifestation of RHD.

While the pathophysiology has not been fully understood, it is postulated that inflammatory response is the most important part of the pathogenesis of RHD.[@b5-jbm-6-151],[@b6-jbm-6-151] The total white blood cell count is an easy, inexpensive, and widely available means of detecting inflammation. Neutrophils are the major components of leukocytes in peripheral blood. The neutrophil to lymphocyte ratio (NLR) was recently reported to be a marker of thrombosis and inflammation and was found to be associated with the severity and prognosis of several cardiovascular diseases.[@b7-jbm-6-151]--[@b9-jbm-6-151]

The aim of this study was to evaluate the relationship between NLR and the degree of RMS.

Methods
=======

Study population
----------------

This multicenter retrospective study included 300 mitral stenosis (MS) patients who had been admitted to the Department of Cardiology at the Diyarbakır Gazi Yaşargil Education and Research Hospital in Diyarbakır and Ankara Yüksek İhtisas Education and Research Hospital in Ankara, from January 2013 to June 2014. All the patients underwent a clinical examination, ECG, and transthoracic echocardiography. Patients with diabetes mellitus, hypertension, malnutrition, coronary artery disease, acute corticosteroids use, acute infection, chronic renal and hepatic disease, and hematological disease were excluded from the study.

The patients were divided into tertiles according to NLR: 0.85\< NLR ≤1.85 (n=100), 1.86≤ NLR ≤2.46 (n=100), and 2.47≤ NLR ≤7.08 (n=100). Patients with RMS were divided into three groups based on the degree of MS as mild, moderate, and severe RMS. Valve disease severity was defined according to the American Society of Echocardiography and American College of Cardiology/American Heart Association guidelines for the management of valvular heart disease.[@b10-jbm-6-151] Venous peripheral blood samples were taken on admission. Blood samples were drawn into standardized tubes containing dipotassium ethylenediaminetetraacetic acid (EDTA) and delivered to the laboratory within a few minutes. All hematological measurements were performed using an XT-2000i analyzer (Sysmex Corp of America, Long Grove, IL, USA). This study was approved by the Ethics Committee of Ankara Yüksek İhtisas Education and Research Hospital, and informed consent was obtained from all study participants.

Echocardiography
----------------

Two-dimensional and Doppler echocardiography were performed. (Vivid 5 System, 2.5 MHz transducer, GE-Vingmed Ultrasound AS, Horten, Norway). All measurements were taken according to the American Society of Echocardiography guidelines. Mitral valve area was measured by using the pressure half-time method and planimetry of the mitral valve orifice from the short-axis view at the tip of the mitral leaflets. The mean transmitral diastolic pressure gradient was determined by using the Doppler method in the apical four-chamber view. Pulmonary arterial systolic pressure (PASP) was calculated by measuring the velocity of the tricuspid regurgitation jet. Severity of stenosis as defined by the American Society of Echocardiography and endorsed by the American College of Cardiology/American Heart Association valve disease guidelines are as follows: Severe stenosis is associated with a mean transvalvular gradient \>10 mmHg, PASP \>50 mmHg, and valve area \<1.0 cm^2^.Moderate stenosis is associated with a mean transvalvular gradient of 5--10 mmHg, PASP pressures of 30--50 mmHg, and a valve area of 1.0--1.5 cm^2^.Mild stenosis is associated with a mean transvalvular gradient of \<5 mmHg, PASP pressures \<30 mmHg, and a valve area \>1.5 cm^2^.

Statistical analysis
--------------------

Data were analyzed with the SPSS software version 15.0 for Windows (SPSS Inc., Chicago, IL, USA). Categorical variables were presented as frequency and percentage. The χ^2^ test and Fisher's exact test were used to compare categorical variables. The Kolmogorov--Smirnov test was used to assess the distribution of continuous variables. Student's *t*-test was used for variables with normal distribution, and the values were presented as mean ± standard deviation. Continuous variables without normal distribution were analyzed using Mann--Whitney *U*-test, and the values obtained were presented as median (50th) values and interquartile ranges (25th and 75th). One-way analysis of variance and Kruskal--Wallis test were used for parametric and nonparametric variables to compare tertiles, respectively. Multivariate logistic regression analysis was used to evaluate the independent association of the risk of severe RMS. Parameters with a *P*-value of less than 0.1 in univariate analysis were included in the model. The odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. A two-tailed *P*-value of \<0.05 was considered statistically significant.

Results
=======

A total of 300 consecutive patients were enrolled in the study. The mean age of the patients were 48.5±12.1 years, and 64 (21.3%) were male. The baseline characteristics are presented in [Table 1](#t1-jbm-6-151){ref-type="table"}. No significant differences were found in the presence of mitral regurgitation, hypertension, diabetes mellitus, and biochemical parameters. The patients with severe RMS had significantly elevated NLR, mean platelet volume, and PASP values compared to patients with moderate and mild MS (*P*\<0.001, *P*\<0.001, *P*\<0.001, respectively). Spearman's correlation analysis revealed a weak negative correlation between NLR and mitral valve area (*r*~s~=−0.244, *P*\<0.001) and a positive moderate correlation between NLR and mean transmitral gradient (*r*~s~=0.277, *P*\<0.001) values.

After the initial evaluation, 187 patients with moderate-to-severe RMS (Group 1) and 113 patients with mild RMS (Group 2) were reassessed ([Table 2](#t2-jbm-6-151){ref-type="table"}). The patients in Group 1 had higher NLR values. An univariate linear regression analysis for the relationship between severity of MS and other variables is shown in [Table 3](#t3-jbm-6-151){ref-type="table"}. Multivariate binary logistic regression analysis revealed that high levels of NLR, PSAP, and left atrium size were independent predictors of severe RMS ([Table 3](#t3-jbm-6-151){ref-type="table"}). RMS was associated with NLR (OR =0.65, 95% CI: 0.47--0.89, *P*=0.008), left atrium size (OR =0.49, 95% CI: 0.29--0.82, *P*=0.006), and PSAP values (OR =0.94, 95% CI: 0.90--0.97, *P*\<0.001).

Patients were divided into three tertiles based on the NLR levels. The relationship between RMS and NLR tertiles are presented in [Table 4](#t4-jbm-6-151){ref-type="table"} and [Figure 1](#f1-jbm-6-151){ref-type="fig"}. Moderate-to-severe RMS incidences were significantly higher among patients in the tertile 3 (OR =2.8, 95% CI: 1.5--5.0, *P*\<0.001).

Discussion
==========

In the present study, we found that an increased NLR was independently associated with the degree of RMS.

Chronic RHD is one of the latest sequels of ARF occurring in approximately 30% of patients with rheumatic fever.[@b11-jbm-6-151] In case of ARF, several inflammatory cells, such as neutrophils, macrophages, and T and B lymphocytes, infiltrate both the myocardium and the valves. The healing process of rheumatic carditis results in varying degrees of fibrosis and valve damage. RMS is a common manifestation of RHD. Inflammatory process plays a key role in RHD, and previous studies have shown that there is ongoing chronic inflammation in rheumatic mitral valve disease. In the previous studies, it was shown that levels of chronic inflammatory markers were higher in patients with rheumatic valve disease than control groups.[@b12-jbm-6-151] Gölbasi et al reported that levels of C-reactive protein were higher in patients with rheumatic valve disease than in the control groups and they concluded that this could be a sign of chronic ongoing inflammation.[@b13-jbm-6-151] Similarly, Alyan et al showed that C-reactive protein was significantly higher in patients with RMS than in the control group and independently correlated with the Wilkins valve score.[@b14-jbm-6-151] Low-grade inflammation and oxygen radicals released by activated neutrophils can be shown in circulation in the coronary sinus.[@b15-jbm-6-151]--[@b17-jbm-6-151] NLR, which can be derived from the white blood cell count, is a new marker of systemic inflammation. NLR provides an indicator of the inflammatory status that combines both neutrophils and lymphocytes. The main cause of increased NLR was probably the increased apoptosis of lymphocytes triggered by the increased inflammatory status in RMS. In a recent study, Öztürk et al reported that higher NLR was associated with spontaneous echocardiographic contrast in RMS.[@b18-jbm-6-151] NLR is a new marker of inflammation that is associated with the severity of coronary artery disease, long-term mortality in patients undergoing primary percutaneous coronary intervention, and cardiac mortality in patients with stable coronary artery disease.[@b7-jbm-6-151]--[@b9-jbm-6-151] In a recent study, it was reported that a high NLR was associated with thrombolysis failure in ST-elevation myocardial infarction patients treated with thrombolytic therapy.[@b19-jbm-6-151] Horne et al reported that higher NLR was associated with worse clinical outcome in patients with ischemic heart disease without ST-elevation myocardial infarction.[@b20-jbm-6-151] In addition to those studies, Cho et al report that NLR at 24 hours after admission is a predictor of mortality in patients with ST-elevation myocardial infarction who undergo percutaneous coronary intervention.[@b21-jbm-6-151] Turak et al showed that a high NLR predicted in-hospital mortality and cerebrovascular events in patients with infective endocarditis.[@b22-jbm-6-151]

Although Akboğa et al found that NLR was significantly increased in patients with RMS than control groups, NLR did not reach statistical significance in MS groups.[@b23-jbm-6-151] On the other hand, in a recent study, it was shown that high NLR predicted presence and severity of MS in patients with rheumatic mitral valve disease.[@b24-jbm-6-151] However, Akboğa et al subdivided the RMS into mild-moderate and severe MS groups; we not only assessed mild, moderate and severe MS groups, but also reassessed mild and moderate-severe MS. Our study differs from the previous studies in that we evaluated the relationship between NLR and the degree of RMS. We subdivided the RMS into mild, moderate, and severe MS groups and showed that high NLR is associated with severity of MS.

Therefore, it may be an auxiliary parameter when used in combination with other parameters known to be associated with RMS.

Our study had several limitations. First, this was a retrospective study and included a relatively small number of patients. Second, we enrolled only patients with complete blood counts at admission. Therefore, the present results cannot be directly extrapolated to all patients with RHD. Third, there is no control group, and this is another limitation of the study.

Conclusion
==========

NLR is a new inflammatory marker and a simple, rapid, and easily accessible prognostic parameter that can be associated with severity of RMS in patients with RHD.
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###### 

Comparison of the patient's baseline characteristics according to severity of mitral stenosis

                                       Severe MS (Group 1), n=29   Moderate MS (Group 2), n=158   Mild MS (Group 3), n=113   *P*
  ------------------------------------ --------------------------- ------------------------------ -------------------------- ---------
  Age, years                           48±14                       49±12                          48±12                      0.543
  Male, n (%)                          41                          22                             15                         0.008
  Ejection fraction, %                 60 (60--65)                 60 (60--60)                    60 (60--60)                0.097
  MVA, cm^2^                           0.8±0.08                    1.3±0.2                        1.8±0.1                    \<0.001
  Maximum transmitral gradient, mmHg   22 (19--26)                 15 (13--18)                    11 (9--13)                 \<0.001
  Mean transmitral gradient, mmHg      12 (11--14)                 7 (6--9)                       5 (4--7)                   \<0.001
  Left atrium, cm                      5.0 (4.9--5.3)              5.0 (4.0--5.0)                 4.0 (4.0--5.0)             \<0.001
  Mitral regurgitation, %                                                                                                    0.149
   0                                   21                          20                             13                         
   1                                   35                          50                             45                         
   2                                   45                          30                             42                         
  PASP, mmHg                           58 (45--67)                 39 (33--43)                    33 (30--38)                \<0.001
  Hemoglobin, g/dL                     13.8±1.4                    13.6±1.7                       13.7±1.5                   0.724
  Hematocrit, %                        42±4                        41±4                           42±4                       0.526
  WBC count, ×10^3^/mm^3^              7.9 (7.1--8.4)              7.0 (6.0--8.0)                 7.0 (6.0--8.0)             0.085
  Neutrophil count, ×10^3^/mm^3^       4.9±1.0                     4.5±1.3                        4.3±1.2                    0.025
  Lymphocyte count, ×10^3^/mm^3^       1.9 (1.5--2.3)              2.0 (1.6--2.3)                 2.1 (1.7--2.5)             0.031
  RDW, %                               14.5 (13.9--15.1)           13.8 (13.2--14.7)              13.7 (13.3--14.5)          0.008
  MPV, fL                              10.4 (9.4--11.0)            9.2 (8.6--9.7)                 9.1 (8.7--9.7)             \<0.001
  Glucose, mg/dL                       94 (89--106)                97 (91--105)                   96 (89--104)               0.570
  BUN                                  26 (23--32)                 28 (24--34)                    27 (24--34)                0.600
  Creatinine, mg/dL                    0.86±0.20                   0.83±0.19                      0.83±0.16                  0.654
  LDL, mg/dL                           118±29                      113±32                         110±30                     0.413
  HDL, mg/dL                           43 (41--51)                 47 (41--58)                    47 (41--55)                0.322
  Triglyceride, mg/dL                  176 (100--205)              125 (83--187)                  116 (86--180)              0.171
  Total cholesterol, mg/dL             196±37                      191±42                         187±37                     0.557
  NLR, n                               2.55 (2.23--3.14)           2.20 (1.76--2.88)              1.89 (1.54--2.48)          \<0.001

**Notes:** Data are expressed as mean ± standard deviation or count (percentage) for categorical variables. *P*\<0.05 compared according to degree of mitral stenosis.

**Abbreviations:** HDL, high density lipoprotein; LDL, low density lipoprotein; MPV, mean platelet volume; MS, mitral stenosis; MVA, mitral valve area; NLR, neutrophil to lymphocyte ratio; PASP, pulmonary artery systolic pressure; RDW, red cell distribution width; WBC, white blood cell; BUN, Blood urea nitrogen.

###### 

Comparison of the NLR levels according to MVA\<1.5 cm or not

        Moderate to severe ≤1.5 cm^2^, n=187   Mild \>1.5 cm^2^, n=113   *P*
  ----- -------------------------------------- ------------------------- ---------
  NLR   2.24 (1.83--2.93)                      1.89 (1.54--2.48)         \<0.001

**Notes:** Data are expressed as mean ± standard deviation or count (percentage) for categorical variables. *P*\<0.05 compared with the moderate-to-severe mitral stenosis and mild mitral stenosis.

**Abbreviations:** NLR, neutrophil to lymphocyte ratio; MPV, mean platelet volume.

###### 

Independent predictors of severity of mitral stenosis

                Univariate analysis   Multivariate analysis                                 
  ------------- --------------------- ----------------------- --------- ------ ------------ -------
  Male          1.84                  0.99--3.40              0.051                         
  Left atrium   0.28                  0.18--0.44              \<0.001   0.49   0.29--0.82   0.006
  PASP          0.92                  0.89--0.95              \<0.001   0.94   0.90--0.97   0.001
  WBC           0.94                  0.80--1.10              0.413                         
  Neutrophil    0.81                  0.67--0.99              0.036                         
  Lymphocyte    1.73                  1.14--2.61              0.010                         
  RDW           0.89                  0.73--1.09              0.260                         
  MPV           0.76                  0.59--0.98              0.034                         
  NLR           0.56                  0.41--0.77              \<0.001   0.65   0.47--0.89   0.008

**Abbreviations:** CI, confidence interval; MPV, mean platelet volume; NLR, neutrophil to lymphocyte ratio; OR, odds ratio; PASP, pulmonary artery systolic pressure; RDW, red cell distribution width; WBC, white blood cell.

###### 

The patients were divided into tertiles according to NLR

                     Mild MS   Moderate-severe MS   OR    95% CI     *P*
  ------------------ --------- -------------------- ----- ---------- -------
  Tertile 1, n=100   46%       25%                  1                
  Tertile 2, n=100   29%       36%                  2.2   1.2--3.9   0.007
  Tertile 3, n=100   25%       39%                  2.8   1.5--5.0   0.001

**Abbreviations:** MS, mitral stenosis; CI, confidence interval; OR, odds ratio; NLR, neutrophil to lymphocyte ratio.
